Verbanck Marie, Canouil Mickaël, Leloire Audrey, Dhennin Véronique, Coumoul Xavier, Yengo Loïc, Froguel Philippe, Poulain-Godefroy Odile
University Lille, CNRS, CHU Lille, Institut Pasteur de Lille, UMR 8199-EGID, Lille, France.
INSERM UMR-S 1124, Toxicologie Pharmacologie et Signalisation cellulaire, Paris, France; Université Paris Descartes, ComUE Sorbonne Paris Cité, Paris, France.
PLoS One. 2017 Jun 19;12(6):e0179583. doi: 10.1371/journal.pone.0179583. eCollection 2017.
Bisphenol A (BPA) exposure has been suspected to be associated with deleterious effects on health including obesity and metabolically-linked diseases. Although bisphenols F (BPF) and S (BPS) are BPA structural analogs commonly used in many marketed products as a replacement for BPA, only sparse toxicological data are available yet. Our objective was to comprehensively characterize bisphenols gene targets in a human primary adipocyte model, in order to determine whether they may induce cellular dysfunction, using chronic exposure at two concentrations: a "low-dose" similar to the dose usually encountered in human biological fluids and a higher dose. Therefore, BPA, BPF and BPS have been added at 10 nM or 10 μM during the differentiation of human primary adipocytes from subcutaneous fat of three non-diabetic Caucasian female patients. Gene expression (mRNA/lncRNA) arrays and microRNA arrays, have been used to assess coding and non-coding RNA changes. We detected significantly deregulated mRNA/lncRNA and miRNA at low and high doses. Enrichment in "cancer" and "organismal injury and abnormalities" related pathways was found in response to the three products. Some long intergenic non-coding RNAs and small nucleolar RNAs were differentially expressed suggesting that bisphenols may also activate multiple cellular processes and epigenetic modifications. The analysis of upstream regulators of deregulated genes highlighted hormones or hormone-like chemicals suggesting that BPS and BPF can be suspected to interfere, just like BPA, with hormonal regulation and have to be considered as endocrine disruptors. All these results suggest that as BPA, its substitutes BPS and BPF should be used with the same restrictions.
双酚A(BPA)暴露被怀疑与包括肥胖症和代谢相关疾病在内的健康有害影响有关。尽管双酚F(BPF)和双酚S(BPS)是双酚A的结构类似物,在许多市售产品中常用作双酚A的替代品,但目前仅有稀少的毒理学数据。我们的目标是在人类原代脂肪细胞模型中全面表征双酚的基因靶点,以便通过两种浓度的慢性暴露来确定它们是否可能诱导细胞功能障碍:一种“低剂量”类似于人类生物体液中通常遇到的剂量,以及一种更高的剂量。因此,在来自三名非糖尿病白种女性患者皮下脂肪的人类原代脂肪细胞分化过程中,已添加10 nM或10 μM的双酚A、双酚F和双酚S。基因表达(mRNA/lncRNA)阵列和微小RNA阵列已用于评估编码和非编码RNA的变化。我们在低剂量和高剂量下均检测到显著失调的mRNA/lncRNA和微小RNA。发现对这三种产品的反应中,与“癌症”和“机体损伤及异常”相关的途径出现富集。一些长链基因间非编码RNA和小核仁RNA存在差异表达,表明双酚可能还会激活多种细胞过程和表观遗传修饰。对失调基因上游调节因子的分析突出了激素或激素样化学物质,这表明双酚S和双酚F可能像双酚A一样,被怀疑干扰激素调节,必须被视为内分泌干扰物。所有这些结果表明,与双酚A一样,其替代品双酚S和双酚F的使用也应受到同样的限制。